In MS mice, increased expressions of the cytokines IL-1β, IL-6, and TNF-α were observed (IL-1β: p = 0.0004; IL-6: p = 0.0012; TNF-α: p = 0.0046, IL-10: p = 0.0175) while the level of IL-10 decreased (IL-10: p = 0.0175); the GLTs treatment did not affect the expression of IL-10 but reduced the increased expressions of the other cytokines (IL-1β: p = 0.0018; IL-6: p = 0.0024; TNF-α: p = 0.0010). The gene discussed is IL10; the disease is myeloid sarcoma.